Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.

Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...

書誌詳細
主要な著者:	Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P
フォーマット:	Journal article
言語:	English
出版事項:	2007

類似資料

Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
著者:: Roelofs, A, 等
出版事項: (2005)

APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
著者:: Croucher, P, 等
出版事項: (2002)

Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
著者:: Roelofs, A, 等
出版事項: (2007)

Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
著者:: Roelofs, A, 等
出版事項: (2006)

Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
著者:: Croucher, P, 等
出版事項: (2003)

Myeloma cells can promote osteoclastic activity rather than osteoclast recruitment in vitro; Evidence from the 5T2MM murine model of myeloma
著者:: Mueller, G, 等
出版事項: (2004)

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
著者:: Mueller, G, 等
出版事項: (2004)

HMG CoA reductase inhibitors in the treatment of hypercholesterolaemias.
著者:: Aronson, J, 等
出版事項: (1990)

Pleiotropic effects of the HMG-CoA reductase inhibitors
著者:: Mihos CG, 等
出版事項: (2011-04-01)

Regulation of HMG-CoA reductase activity in plants.
著者:: B A Stermer, 等
出版事項: (1994-07-01)

Activation of HMG-CoA reductase by microsomal phosphatase
著者:: K R Feingold, 等
出版事項: (1983-03-01)

The discovery and development of HMG-CoA reductase inhibitors.
著者:: A Endo
出版事項: (1992-11-01)

HMG-CoA reductase kinase: measurement of activity by methods that preclude interference by inhibitors of HMG-CoA reductase activity or by mevalonate kinase.
著者:: H J Harwood, Jr, 等
出版事項: (1982-07-01)

Bisphosphonates--mechanisms of action in multiple myeloma.
著者:: Shipman, C, 等
出版事項: (2000)

The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
著者:: Shipman, C, 等
出版事項: (2000)

Osteoprotegerin and the development of myeloma bone disease
著者:: Croucher, P, 等
出版事項: (2004)

HMG CoA reductase of intestinal mucosa and liver of the rat
著者:: S. Shefer, 等
出版事項: (1972-05-01)

HMG-CoA reductase is not the site of the primary defect in phytosterolemia
著者:: G.M.B. Berger, 等
出版事項: (1998-05-01)

Genetic and dietary interactions in the regulation of HMG-CoA reductase gene expression.
著者:: JJ Hwa, 等
出版事項: (1992-05-01)

Bisphosphonates and in vivo models of multiple myeloma - Reply
著者:: Shipman, C, 等
出版事項: (2001)

The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
著者:: Marc M Schumacher, 等
出版事項: (2015-03-01)

Stimulatory effect of dietary lipid and cholestyramine on hepatic HMG CoA reductase
著者:: Stanley Goldfarb, 等
出版事項: (1972-11-01)

QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition
著者:: Robert Ancuceanu, 等
出版事項: (2024-10-01)

HMG-CoA Reductase Inhibitors from Monascus-Fermented Rice
著者:: Xuemei Li, 等
出版事項: (2013-01-01)

Eupatilin Alleviates Hyperlipidemia in Mice by Inhibiting HMG-CoA Reductase
著者:: Kyung-Joo Kim, 等
出版事項: (2023-01-01)

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation
著者:: Paolo Gelosa, 等
出版事項: (2007-11-01)

Induction of HMG CoA reductase by the administration of 20,25-diazacholesterol
著者:: R Langdon, 等
出版事項: (1977-01-01)

MTD–CoMSIA modelling of HMG-CoA reductase inhibitors
著者:: DANIEL M. DUDA-SEIMAN, 等
出版事項: (2011-01-01)

Measurement of human leukocyte microsomal HMG-CoA reductase activity.
著者:: H J Harwood, Jr, 等
出版事項: (1984-09-01)

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo
著者:: Jobin Jean, 等
出版事項: (2004-05-01)

Diurnal variation of HMG CoA reductase activity in rat intestine
著者:: S. Shefer, 等
出版事項: (1972-09-01)

Chronic Onset Form of Anti-HMG-CoA Reductase Myopathy
著者:: Noel Lorenzo Villalba, 等
出版事項: (2021-06-01)

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
著者:: Croucher, P, 等
出版事項: (2001)

Mutations within the membrane domain of HMG-CoA reductase confer resistance to sterol-accelerated degradation
著者:: Peter C.W. Lee, 等
出版事項: (2007-02-01)

Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity
著者:: Gene C. Ness, 等
出版事項: (1998-01-01)

Rapid reverse phase-HPLC assay of HMG-CoA reductase activity
著者:: Matteo Mozzicafreddo, 等
出版事項: (2010-08-01)

Inactivation of rat liver HMG-CoA reductase phosphatases by polycarboxylic acids.
著者:: F G Hegardt, 等
出版事項: (1983-07-01)

Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor
著者:: Sucharita Bose, 等
出版事項: (2023-04-01)

Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
著者:: Hongwen Chen, 等
出版事項: (2022-07-01)

Are Point Mutations in HMG-CoA Reductases (Hmg1 and Hmg2) a Step towards Azole Resistance in <i>Aspergillus fumigatus</i>?
著者:: Irene Gonzalez-Jimenez, 等
出版事項: (2021-10-01)